Tesamorelin is highly effective in reducing visceral fat in HIV/AIDS patients, with trials reporting up to -25% reduction in this parameter from baseline within 52 weeks [17]
The percentage is similar to lighter men, but the raw numbers are more dramatic
Key Takeaways Peripheral artery disease (PAD) affects 8-12 million Americans and causes leg coldness by reducing blood flow through narrowed arteriesankle-brachial index below 0.9 indicates significant blockage
Exercise research shows benefits for preserving muscle mass, which supports metabolic health and may make weight maintenance easier
Saxenda, DailyMed (2023) Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study, Journal of Diabetes Investigation (2020) Cardiovascular events, acute hospitalizations, and mortality in patients with Type 2 diabetes mellitus who initiate empagliflozin versus liraglutide: A comparative effectiveness study, Journal of the American Heart Association (2021) Comparative effectiveness of empagliflozin vs